37 results
D
BTAX
Biostax Corp.
2 Oct 12
$3M in equity / options, sold $200K, 2 investors
12:00am
Utilities
Energy Conservation
Environmental Services
Oil & Gas
Other Energy
Health Care
Biotechnology
Health Insurance
Hospitals & Physicians …
Pharmaceuticals
Other Health Care
Manufacturing
Real Estate
Commercial
Construction
REITS & Finance
Residential
Other Real Estate
Retailing
D/A
BTAX
Biostax Corp.
25 Sep 13
Indefinite amount in equity / options, sold $2.89M, 35 investors
12:00am
Mining
Electric Utilities
Energy Conservation
Environmental Services
Oil & Gas
Other Energy
Health Care
Biotechnology
Health Insurance …
Hospitals & Physicians
Pharmaceuticals
Other Health Care
Manufacturing
Real Estate
Commercial
Construction
REITS & Finance
Residential
Other Real
D
BTAX
Biostax Corp.
31 Aug 22
$5M in debt
2:58pm
Health Care
Biotechnology
Health Insurance
Hospitals & Physicians
Pharmaceuticals
Other Health Care
Manufacturing
Real Estate
Commercial
8-K
EX-99.1
BTAX
Biostax Corp.
22 Jul 22
Immune Therapeutics, Inc. Appoints Dr. Stephen Wilson as Chief Executive Officer
3:44pm
. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition
8-K
EX-99.1
BTAX
Biostax Corp.
24 Oct 23
Amendments to Articles of Incorporation or Bylaws
9:00am
seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition
8-K
EX-99.1
eo8z a22gq
27 Sep 22
Immune Therapeutics Appoints H. Louis Salomonksy to its Board of Directors
2:37pm
8-K
EX-99.1
6nfj5
2 Nov 23
Biostax Announces the Appointment of Ms. Mary Clay Caperton to its Board of Directors
9:00am
8-K
EX-99.1
hv01223r 8x1jint2
9 Nov 22
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-99.1
9y9p0r0e3
4 Aug 22
Immune Therapeutics Appoints Chief Financial Officer and Chief Operating Officer
1:00pm
8-K
EX-99.1
krgjb4l
20 Apr 23
Entry into a Material Definitive Agreement
9:00am
10-12G
o7gdwu
22 Apr 13
Registration of securities
12:00am
10-12G/A
pdrw4j 3f9sy9a
7 Jun 13
Registration of securities (amended)
12:00am
10-K
g016cc 3o
31 Mar 14
Annual report
12:00am
CORRESP
08p43 ke0uzweaaqve
18 Jul 13
Correspondence with SEC
12:00am